Becton Dickinson stock holds near Q3 highs as dividend approaches
Published on 09/17/2026 at 15:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Becton, Dickinson and Company stock (ISIN US0718131099) closed at USD 185.92 on the NYSE on September 15, 2026, up 1.65 percent from a prior close of USD 182.91, as investors digested strong fiscal third quarter 2026 results and an upcoming dividend payment.
Q3 2026 figures underpin Becton Dickinson stock
According to Ad-hoc-news, Becton Dickinson reported fiscal third quarter 2026 revenue of about USD 5.0 billion for the period ended June 30, 2026, representing growth of 5.4 percent compared with the same quarter a year earlier.
In the same report, adjusted EPS for Q3 2026 was stated at USD 3.23, providing a clear improvement in profitability versus the prior-year quarter and giving the company room to maintain its shareholder returns policy.Ad-hoc-news
Dividend and analyst expectations support the shares
For income-focused investors, the near-term catalyst is a quarterly dividend of USD 1.05 per share payable on September 30, 2026, which corresponds to an annualized dividend of USD 4.20 and a forward yield of roughly 2.3 percent at recent share prices, according to Ad-hoc-news.
Research coverage summarized by Ad-hoc-news indicates that consensus price targets cluster around the mid USD 180s, with one overview citing a band near USD 186.38 and a mixed sentiment profile of roughly 47 percent buy ratings and 50 percent hold recommendations.
That mix suggests that while Becton Dickinson stock already trades close to many analysts' fair-value estimates, further upside will depend on continued earnings momentum beyond the 5.4 percent revenue growth and USD 3.23 adjusted EPS delivered in Q3 2026 and on the company's execution in its medical devices and diagnostics franchises.Ad-hoc-news
Stock levels and market context
Price snapshots from major stock portals such as Yahoo Finance show Becton Dickinson shares trading intraday around USD 184.17 on September 17, 2026, roughly 0.94 percent below the previous close of USD 185.92, with the session open at USD 185.18 and trading taking place on the NYSE in USD.
The same overviews place the stock's recent closing level of USD 185.92 on September 15, 2026 against a market capitalization near USD 50.64 billion, highlighting that the company remains a large-cap health care name with meaningful index presence in benchmarks such as the S&P 500.Ad-hoc-news
As of the latest measurements cited by Ad-hoc-news, Becton Dickinson stock recently traded at about USD 185.91 and showed a gain of 4.53 percent over a defined recent measurement period, placing the shares close to but not materially above the cited consensus target band and indicating that the market has already priced in a good portion of the strong Q3 2026 performance.
Becton Dickinson stock key data
- Company: Becton, Dickinson and Company Inc.
- ISIN: US0718131099
- Ticker: BDX
- Trading venue: NYSE
- Price (as of September 17, 2026, 14:50): 184.17 USD
- Market capitalization: 50,640,000,000 USD (as of September 15, 2026)
- Sector / Industry: Health Care / Medical Instruments and Supplies
- Index membership: S&P 500
- Next earnings date: November 5, 2026
